Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6195)
  2. Meeting Abstract (6166)
  3. Review (401)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (160)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11094)
  2. Hematologic Malignancies, Division of (10645)
  3. GSK Faculty (5449)
  4. Adult Leukemia (3723)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (946)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (317)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (268)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1669)
  3. Nature Publishing Group (1118)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular determinants of decitabine response in chronic myelomonocytic leukemia
    Meeting Abstract

    Rossi, A.; Meldi, K.; Martinez, A. B. V.; Abdel-Wahab, O.; Micol, J. B.; Qin, T. T.; Buchi, F.; Masala, E.; Sanna, A.; Allione, B.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Improved survival in patients with first relapsed or refractory acute myeloid leukemia (AML) treated with vosaroxin plus cytarabine versus placebo plus cytarabine: Results of a phase 3 double-blind randomized controlled multinational study (VALOR)
    Meeting Abstract

    Ravandi, F.; Ritchie, E.; Sayar, H.; Lancet, J.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G.; Jabbour, E.; Erba, H. P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid lukemia
    Meeting Abstract

    Rampal, R. K.; Alkalin, A.; Madzo, J.; Vasanthakumar, A.; Pronier, E.; Patel, J. P.; Li, Y. S.; Ahn, J.; Abdel-Wahab, O.; Shih, A. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • AMC075: The combination of vorinostat with chemotherapy and rituximab is tolerable and feasible in HIV-related B-cell non-Hodgkin's lymphoma with high-risk features
    Meeting Abstract

    Ramos, J. C.; Sparano, J.; Moore, P.; Lee, J. Y.; Rudek, M. A.; Ambinder, R. F.; Cesarman, E.; Noy, A.; Mitsuyasu, R. T.
    Blood (2014)

    Fulltext@MSK | Save
  • Engineered T cell receptor-mimic antibody, (TCRm) chimeric antigen receptor (CAR) T cells against the intracellular protein Wilms tumor-1 (WT1) for treatment of hematologic and solid cancers
    Meeting Abstract

    Rafiq, S.; Dao, T.; Liu, C.; Scheinberg, D. A.; Brentjens, R. J.
    Blood (2014)

    Fulltext@MSK | Save
  • T cells in CTCL have an exhausted phenotype while cutaneous dendritic cells display a normally activated mature phenotype
    Meeting Abstract

    Querfeld, C.; Curran, S. A.; Leung, S.; Myskowski, P. L.; Horwitz, S. M.; Halpern, A. C.; Young, J. W.
    Blood (2014)

    Fulltext@MSK | Save
  • Day 45 lymphocyte recovery is independently associated with transplant-related mortality after adult myeloablative double-unit cord blood transplantation (dCBT)
    Meeting Abstract

    Purtill, D.; Ponce, D. M.; Devlin, S. M.; Lubin, M. N.; Dahi, P. B.; Giralt, S. A.; Perales, M. A.; O'Reilly, R. J.; van den Brink, M. R. M.; Young, J. W.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Analysis of 129 myeloablative double-unit cord blood transplantation recipients demonstrates an independent association between non-dominant unit TNC dose and engraftment suggesting a facilitation effect
    Meeting Abstract

    Purtill, D.; Lubin, M. N.; Ponce, D. M.; Giralt, S.; Perales, M. A.; O'Reilly, R. J.; Van Den Brink, M.; Young, J. W.; Scaradavou, A.; Stevens, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Third party donor derived CMV specific T vells for the treatment of refractory CMV viremia and disease after hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S. E.; Hasan, A.; Koehne, G.; Doubrovina, E.; Sauter, C. S.; Barker, J. N.; Baroudy, K.; Boulad, F.; Giralt, S.; Khalaf, R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma (AITL)
    Meeting Abstract

    Pro, B.; Horwitz, S. M.; Prince, H. M.; Foss, F. M.; Sokol, L.; Greenwood, M.; Caballero, D.; Morschhauser, F.; Wilhelm, M.; Pinter-Brown, L.; more...
    Blood (2014)

    Fulltext@MSK | Save